Post-earnings recap
Reported
Thu, Aug 6, 2026
EPS actual
$0.52
EPS est.
$0.36
EPS surprise
+45.25%
1-day move
-4.43%
DENTSPLY SIRONA Inc. reported an earnings per share that exceeded expectations significantly, with a surprise of over 45%. However, the stock reacted negatively, declining by 4.43%. This drop may indicate investor concerns despite the strong EPS performance, possibly due to the lack of revenue information and guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.52 | N/A | +45.25% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Est. EPS
$6.10
Est. Rev
$5.0B
Impl. Move
±5.3%
DENTSPLY SIRONA Inc. (XRAY) is a leading manufacturer of health care supplies, particularly in the dental sector. With a market cap of $2 billion, the company plays a crucial role in providing innovative products and technologies that enhance dental care and patient outcomes.
Last quarter
In Q1 2026, DENTSPLY SIRONA reported an EPS of $0.27, slightly missing expectations. The stock reacted positively the following day, gaining 1.52%.
Management promises and guidance
EPS beat streak
1Q
EPS beat rate
50%
Avg EPS surprise
+4.57%
Avg 1-day reaction
-5.02%
Analysts have mixed expectations for DENTSPLY SIRONA's upcoming earnings, given recent performance and the competitive landscape. Investors are keen to see if the company can meet or exceed EPS estimates.
Bull case
If DENTSPLY SIRONA delivers strong EPS growth and demonstrates solid revenue growth, it could signal a recovery and renewed investor confidence.
Bear case
Conversely, if the company misses EPS expectations again, it may raise concerns about its ability to compete effectively in the market.
Key metrics to watch
Earnings Per Share (EPS)
$0.28EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Revenue Growth
N/ARevenue growth reflects the company's ability to expand its market presence and sales, which is vital for long-term success.
The print will turn on these.
Q1
Will the EPS meet or exceed the expected $0.28, and what factors contributed to this performance?
The EPS figure is critical for assessing the company's profitability and could significantly influence stock movement.
Q2
What insights can management provide regarding revenue growth and market share expansion?
Understanding revenue trends and market positioning is essential for evaluating the company's future prospects.
Why consensus could be wrong
The Street may be underestimating DENTSPLY SIRONA's potential for a turnaround, especially given its recent focus on product innovation and market expansion.
Supporting evidence
The company has shown resilience with a positive stock reaction after recent earnings, despite missing EPS.
Options pricing suggests a significant move is expected, indicating heightened investor interest.
Management's commitment to operational efficiency could lead to improved margins.
Key risk
If the company demonstrates a strong recovery in EPS and revenue growth, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
Investors are weighing the company's ability to recover from recent earnings misses and its strategies for growth.
Bull confirmed if
An EPS of $0.28 or higher, coupled with positive commentary on revenue growth, would confirm the bull case.
Bear confirmed if
An EPS below $0.27, with concerns about revenue stagnation, would support the bear case.
What the market is pricing for the move.
Implied Move
±8.69%
Historical Avg
±9.5%
The options market is pricing in an expected move of about 8.7% in either direction following the earnings report.
Options are pricing ±8.7% while XRAY has averaged ±9.5% over the last 8 prints — setup is roughly in line with history.
ATM IV
0.5%
30d HV
36.7%
Cross-company pattern from 30 similar setups.
Prior-quarter miss + options pricing in-line setup in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
117.65%
of float
Insider
0.65%
of float
Holders
493
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
26,711,079 sh · $228.1M
13.40%
38.8%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If DENTSPLY SIRONA beats expectations and raises guidance, history suggests a potential stock increase of around 5% based on past performance.
In line / cautious
If results are in line with expectations but management's commentary is cautious, the stock may see a muted reaction.
Miss
A miss on EPS could lead to a decline of approximately 3.9%, consistent with past performance when expectations were not met.
The lines on the call that would change the story.
Gross Margin
N/AGross margin indicates how efficiently the company is producing its products and managing costs, impacting overall profitability.
Fuller & Thaler Asset Management Inc.
12,697,269 sh · $108.4M
6.37%
-0.7%
Vanguard Portfolio Management LLC
11,779,851 sh · $100.6M
5.91%
11.9%
AQR Capital Management, LLC
10,458,771 sh · $89.3M
5.25%
163.8%
State Street Corporation
9,285,298 sh · $79.3M
4.66%
28.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.